Patents Assigned to Agency for Science, Technology and Research
  • Patent number: 11485823
    Abstract: The present invention mainly relates to a polymer for delivery of biologically active materials, a complex and a method of synthesis thereof. The polymer comprises a poly(ethylene imine) and at least one monomer, each monomer comprising a modified sugar moiety, preferably galactose, comprising a sulphur atom or a nitrogen atom and a chemical moiety comprising a terminal epoxide for linking the polyethylene imine to the monomer, wherein the sulphur atom or the nitrogen atom links the modified sugar moiety to the chemical moiety. The biologically active material is preferably a gene, siRNA, mRNA or plasmid DNA. Further disclosed is the medical use of said complex in treating a disease caused by a genetic disorder, for example cancer.
    Type: Grant
    Filed: May 23, 2018
    Date of Patent: November 1, 2022
    Assignee: Agency for Science, Technology and Research
    Inventors: Yi-Yan Yang, Chuan Yang, Wei Cheng, Ashlynn Lee
  • Patent number: 11468912
    Abstract: Various embodiments may provide a device for controlling an electromagnetic wave according to various embodiments. The device may include a medium. The device may further include an array of elements in contact with the medium and may be configured to receive the electromagnetic wave. Each element of the array of elements may include a phase change material configured to switch from, at least, a first state to a second state in response to an external input, thereby changing an optical property of the respective element to control the electromagnetic wave.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: October 11, 2022
    Assignee: Agency for Science, Technology and Research
    Inventors: Arseniy Kuznetsov, Ramon Jose Paniagua Dominguez
  • Patent number: 11469501
    Abstract: There is provided a beam steerable antenna system including: an antenna array including a plurality of first radiating elements; a first phase control section coupled to the plurality of first radiating elements, the first phase control section being configured to control a phase of signals from the plurality of first radiating elements to output first phase controlled signals; a first combiner coupled to the first phase control section, the first combiner being configured to combine the first phase controlled signals to output a first combined signal; a first frequency converter coupled to the first combiner, the first frequency converter being configured to downconvert a frequency of the first combined signal to output a first downconverted signal; and a second phase control section coupled to the first frequency converter, the second phase control section being configured to control a phase of the first downconverted signal to output a second phase controlled signal.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: October 11, 2022
    Assignee: Agency for Science, Technology and Research
    Inventors: Xinyi Tang, Francois Po Shin Chin, Xiaoming Peng, Xianming Qing
  • Patent number: 11469755
    Abstract: This document discloses a comparator that is configured to control dead-time between two or more switching transistors. In particular, it is disclosed that the comparator is configured to generate a suitable delay between the switching “OFF” of a transistor and the switching “ON” of another transistor so that the amount of shoot through current flowing between these two transistors are greatly minimized.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: October 11, 2022
    Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventor: Yong-Joon Jeon
  • Patent number: 11453879
    Abstract: The present invention relates to a high-throughput method of screening splicing variants of target genes as drug targets or for characterisation of their biological functions. The disclosure provides a method for the screening of splicing variants, comprising: (a) providing a first antisense oligonucleotide capable of inducing a first splice event on the target gene to express a first splicing variant, and a second antisense oligonucleotide capable of inducing a second splice event on the target gene to express a second splicing variant; (b) hybridising the first and second antisense oligonucleotides to a pre-mRNA of the target gene; and (c) characterising the effect of the splice event.
    Type: Grant
    Filed: August 13, 2018
    Date of Patent: September 27, 2022
    Assignee: Agency for Science, Technology and Research
    Inventor: Keng Boon Wee
  • Patent number: 11434245
    Abstract: The present invention relates to compounds of formula (I), combinations and uses thereof for disease therapy, or a pharmaceutically acceptable salt, solvate or polymorph thereof, including all tautomers and stereoisomers thereof wherein.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: September 6, 2022
    Assignee: Agency for Science, Technology and Research
    Inventors: Jenefer Alam, Soo Yei Ho, Wei Ling Wang, Athisayamani Jeyaraj Duraiswamy
  • Patent number: 11434394
    Abstract: Articles having a thermal imprinted adhesive on a substrate of a plurality of certain conicals have improved bonding strength.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: September 6, 2022
    Assignees: The Procter & Gamble Company, Agency for Science, Technology and Research
    Inventors: Fung Ling Yap, Chang Sheng Lee, Siew Ling Chong, Zhan Cheng
  • Publication number: 20220267376
    Abstract: Peptidomimetic macrocycles that comprise all-D configuration ?-amino acids and bind mouse double minute 2 (MDM2 aka E3 ubiquitin-protein ligase) and MDMX (aka MDM4) are described. These all-D configuration ?-amino acid peptidomimetic macrocycles are protease resistant, cell permeable without inducing membrane disruption, and intracellularly activate p53 by binding MDM2 and MDMX thereby antagonizing MDM2 and MDMX binding to p53. These peptidomimetic macrocycles may be useful in anticancer therapies, particularly in combination with chemotherapy or radiation therapy.
    Type: Application
    Filed: June 16, 2020
    Publication date: August 25, 2022
    Applicants: Merck Sharp & Dohme Corp., Agency for Science, Technology and Research, MSD International GMBH (Singapore Branch)
    Inventors: Pietro Aronica, Christopher J. Brown, Fernando J. Ferrer, Charles W. Johannes, Srinivasaraghavan Kannan, David P. Lane, Anthony W. Partridge, Tomi K. Sawyer, Yaw Sing Tan, Chandra S. Verma, Tsz Ying Yuen
  • Patent number: 11419520
    Abstract: Method for measuring respiratory vibration on a human or animal skin, including emitting an emission light at a first position on the skin and receiving a diffused light from the emission light at a second position on the skin; storing a vibration signal including a light intensity of the diffused light received over time; wherein the vibration signal corresponds to a mechanical vibration of the skin, and extracting a respiratory parameter from the vibration signal. In particular, at least one of the first position and the second position is in proximity to or at a trachea, a neck or a chest. The system for carrying out the method includes an emitter, a receiver, a circuit, and a processing unit. A set of a sensor module and a skin adhesive patch is also provided.
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: August 23, 2022
    Assignee: Agency for Science, Technology and Research
    Inventors: Malini Olivo, Gurpreet Singh, Renzhe Bi
  • Patent number: 11414681
    Abstract: The present invention refers to lambda integrases comprising at least one amino acid mutation at positions 43, 319 and 336 of the lambda integrase as set forth in SEQ ID NO: 1. The invention further refers to nucleic acid molecules comprising the nucleotide sequence encoding the mutant lambda integrase and to host cells containing these nucleic acid molecules. The invention also refers to methods of recombining a nucleic acid of interest into a target nucleic acid in the presence of the mutant lambda integrase and sequence specific recombination kits.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: August 16, 2022
    Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Farid Ghadessy, Jia Wei Siau, Peter Droge, Harshyaa Makhija, Shree Harsh Vijaya Chandra, Sabrina Peter
  • Patent number: 11413812
    Abstract: Systems and methods for continuous printing of a three-dimensional (3D) object are provided. The system includes a resin tank, an optical image source, a support fluid reservoir and a pumping structure. The resin tank is where the 3D object is printed and includes a print bed to form a base of the 3D object. The optical image source modulates light in accordance with a 3D image to vary a degree and pattern of crosslinking in a photocrosslinkable resin in the resin tank. The support fluid reservoir is in fluid communication with the resin tank and includes a support fluid which is immiscible with the photocrosslinkable resin. And the pumping structure is configured to transfer the support fluid from the support fluid reservoir to the resin tank such that the support fluid rises in the resin tank at a same rate as vertical height of a top of the 3D object as the 3D object is printed on the print bed.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: August 16, 2022
    Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Weijie Cyrus Beh, Yiqi Seow, Sau Yin Chin
  • Publication number: 20220251221
    Abstract: Antigen binding molecules capable of binding to CD122 and/or common ? chain (CD132) are disclosed herein. Also disclosed are compositions comprising such antigen binding molecules, and uses and methods using the same.
    Type: Application
    Filed: November 9, 2018
    Publication date: August 11, 2022
    Applicants: Agency for Science, Technology and Research, Euchloe Bio Pte. Ltd.
    Inventors: Peter Brauer, John Edward Connolly, Richard Hopkins, Junyun Lai, Jianrong Lionel Low, Kar Wai Tan, Cheng-l Wang, Siok Ping Yeo
  • Patent number: 11402906
    Abstract: A system for detecting eye blink activity, the system including one or more processors in communication with non-transitory data storage media having instructions stored thereon that, when executed by the one or more processors configure the one or more processors to perform the steps of receiving, with a receiving module, a signal associated with eye blink activity; filtering, at a processing module, the signal to reduce noise from the signal; calculating, at the processing module, a variance of the filtered signal for estimating background noise; removing, at the processing module, background noise associated with the variance; and detecting, at the processing module, eye blink activity by performing duration detection.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: August 2, 2022
    Assignee: Agency for Science, Technology and Research
    Inventors: Kai Keng Ang, Cuntai Guan
  • Patent number: 11397158
    Abstract: Systems and methods for laser stimulated lock-in thermography (LLT) crack detection are provided. The system includes a spatial light modulator and a controller. The spatial light modulator reflects a laser beam to focus the laser beam onto a sample for detection of a crack, hole or scratch. The controller is coupled to the spatial light modulator and controls operation of the spatial light modulator to switch focus of the laser beam onto the sample between a plurality of LLT focus configurations for detection of the crack, hole or scratch on the sample. The method includes using a first one of the plurality of LLT configurations for coarse scanning of the sample to detect a crack, hole or scratch on the sample and, when a crack, hole or scratch is detected on the sample, switching to a second one of the plurality of LLT configurations for fine scanning of the crack, hole or scratch on the sample to determine one or more parameters of the crack, hole or scratch on the sample.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: July 26, 2022
    Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Lu Ding, Jinghua Teng
  • Publication number: 20220227822
    Abstract: The invention relates to an isolated polypeptide encoded by Sghrt and related uses. In addition, methods of assessing a heart function, treating impaired heart function by inhibiting Sghrt, identifying a potential drug for treating impaired heart function, and dedifferentiating and/or proliferating a heart cell by inhibiting Sghrt are claimed.
    Type: Application
    Filed: February 12, 2020
    Publication date: July 21, 2022
    Applicant: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Roger Sik Yin FOO, Dang Vinh DO
  • Patent number: 11393445
    Abstract: A noise management system for a window includes an active noise control (ANC) module and a passive sound absorbing module. The ANC module is disposed in or adjacent a ventilation channel of the window and configured to substantially cancel low-frequency noise entering the ventilation channel. The passive sound absorbing module is disposed in or adjacent to the ventilation channel and configured to absorb both high-frequency noise entering the channel and harmonic sounds generated by the ANC module.
    Type: Grant
    Filed: August 23, 2019
    Date of Patent: July 19, 2022
    Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Meysam Sharifzadeh Mirshekarloo, Kui Yao, Mojtaba Rahimabady, Chin Yaw Tan
  • Patent number: 11385421
    Abstract: Various embodiments may relate to an optical device. The device may include an elongate substrate, an emitter portion at a distal end portion of the elongate substrate, the emitter portion configured to emit light, and an actuator portion at a proximal end portion of the elongate substrate opposite the distal end portion of the elongate substrate. The emitter portion may include a first electrode, a second electrode, and an active layer between the first electrode and the second electrode so that the light is emitted due to an increase in a temperature of the active layer upon application of a first potential difference between the first electrode and the second electrode. The active layer may be patterned to form a photonic crystal layer for enhancing directionality of the emitted light.
    Type: Grant
    Filed: January 16, 2019
    Date of Patent: July 12, 2022
    Assignee: Agency for Science, Technology and Research
    Inventors: Lennon Yao Ting Lee, Lionel You Liang Wong, Alex Yuandong Gu
  • Patent number: 11387451
    Abstract: The present invention generally relates to a method for preparing metal oxide nanosheets. In a preferred embodiment, graphene oxide (GO) or graphite oxide is employed as a template or structure directing agent for the formation of the metal oxide nanosheets, wherein the template is mixed with metal oxide precursor to form a metal oxide precursor-bonded template. Subsequently, the metal oxide precursor-bonded template is calcined to form the metal oxide nanosheets. The present invention also relates to a lithium-ion battery anode comprising the metal oxide nanosheets. In a further preferred embodiment, the battery anode may comprising reduced template, which is reduced graphene oxide (rGO) or reduced graphite oxide.
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: July 12, 2022
    Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Jackie Y. Ying, Ayman Amin Abdelhamid
  • Patent number: 11378558
    Abstract: A method identifies glycopeptides in a sample. The method includes converting a mass spectrum of MS1 precursors of the sample into a plurality of nodes in a graph, each node corresponding to one mass and one retention time of a glycopeptide to be identified in the sample; calculating differences in the mass and/or retention time between all combinations of pairs of the nodes; generating a graph theoretic network of the nodes; and predicting compositions of the glycopeptides in the sample based on the graph theoretic network of the nodes so as to identify the glycopeptides.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: July 5, 2022
    Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Sern Farh Matthew Choo, Terry Nguyen-Khuong, Pauline Mary Rudd
  • Patent number: 11376256
    Abstract: The present specification relates generally to a therapeutic protocol for treating a subject having cancer. Taught herein is a method of treating cancer or reducing the risk of recurrence of cancer in a subject following an anti-cancer therapy.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: July 5, 2022
    Assignee: Agency for Science, Technology and Research
    Inventors: Zhenxun Wang, Wai Leong Tam, Lian Yee Yip, Ying Swan Ho, Zhengwei Wu, Bing Lim